MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

MDT

97.97

-0.41%↓

VEEV

301.82

-1.22%↓

A

141.04

+1.79%↑

HQY

92.06

+4.03%↑

PHR.US

23.23

-0.43%↓

Search

Arbutus Biopharma Corp

Lezárt

4.18 -3.02

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

4.16

Maximum

4.28

Fő mutatók

By Trading Economics

Bevétel

27M

2.5M

Értékesítés

9M

11M

Profit margin

23.494

Munkavállalók

44

EBITDA

27M

2.6M

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

215M

855M

Előző nyitás

7.2

Előző zárás

4.18

Technikai pontszám

By Trading Central

Bizalom

Weak Bearish Evidence

Arbutus Biopharma Corp Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2025. okt. 7. 16:58 UTC

Eredményjelentés

BMW Trims 2025 View, Citing Weaker Performance in China

2025. okt. 7. 23:43 UTC

Piaci beszéd

Nikkei May Trade Rangebound; Takaichi's Policy Steps in Focus -- Market Talk

2025. okt. 7. 23:36 UTC

Piaci beszéd

Gold Edges Higher, Supported by Possible Hedging Demand -- Market Talk

2025. okt. 7. 23:19 UTC

Piaci beszéd

Veem Can Secure More Defense Deals Following Northrop Grumman Win -- Market Talk

2025. okt. 7. 22:50 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

2025. okt. 7. 22:50 UTC

Piaci beszéd

RBNZ Should Take the Option of a Bigger Cut -- Market Talk

2025. okt. 7. 22:40 UTC

Piaci beszéd

South32's Alaskan Project Seen Starting Sooner, Worth More After U.S. Deal -- Market Talk

2025. okt. 7. 21:56 UTC

Piaci beszéd

Global Equities Roundup: Market Talk

2025. okt. 7. 21:56 UTC

Piaci beszéd

Australia Shares Set to Start Day Roughly Flat -- Market Talk

2025. okt. 7. 20:50 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. okt. 7. 20:44 UTC

Forró részvények

Stocks to Watch Tuesday Recap: Oracle, Dell, Trilogy Metals -- WSJ

2025. okt. 7. 19:42 UTC

Piaci beszéd

Treasury Yields Fall as Data Blackout Continues -- Market Talk

2025. okt. 7. 19:23 UTC

Felvásárlások, összeolvadások, átvételek

Private-Equity Stocks Have Gotten Crushed. J.P. Morgan Says This One Is a Buy. -- Barrons.com

2025. okt. 7. 19:07 UTC

Piaci beszéd

Oil Futures Settle Mixed With Higher OPEC+ Supply in View -- Market Talk

2025. okt. 7. 19:02 UTC

Piaci beszéd

U.S. Natural Gas Posts Back-to-Back Gains -- Market Talk

2025. okt. 7. 16:20 UTC

Piaci beszéd

Tech, Media & Telecom Roundup: Market Talk

2025. okt. 7. 16:20 UTC

Piaci beszéd

Basic Materials Roundup: Market Talk

2025. okt. 7. 16:20 UTC

Piaci beszéd

Home Depot Extended Pro Desk Hours Could Drive Sales Growth -- Market Talk

2025. okt. 7. 16:15 UTC

Piaci beszéd

AMD's OpenAI Deal Resets Competitive Landscape for Chips -- Market Talk

2025. okt. 7. 16:15 UTC

Piaci beszéd

Global Commodities Roundup: Market Talk

2025. okt. 7. 15:37 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

2025. okt. 7. 15:37 UTC

Piaci beszéd

Markets for Canadian Aluminum Open Up Beyond U.S. -- Market Talk

2025. okt. 7. 15:33 UTC

Piaci beszéd

Gold Rise Tied to Lower Confidence in Dollar Assets -- Market Talk

2025. okt. 7. 15:25 UTC

Piaci beszéd

Canadian Mining Stocks Rally on U.S. Defense Dept. Deal -- Market Talk

2025. okt. 7. 15:15 UTC

Piaci beszéd

Investors Look to Gold, Bitcoin as Traditional Correlations Break Down -- Market Talk

2025. okt. 7. 15:04 UTC

Piaci beszéd

Market Talk Roundup: Latest on U.S. Politics

2025. okt. 7. 15:04 UTC

Piaci beszéd

Canadian Aluminum Exports Squeezed by Tariffs -- Market Talk

2025. okt. 7. 14:56 UTC

Piaci beszéd

Global Forex and Fixed Income Roundup: Market Talk

2025. okt. 7. 14:56 UTC

Piaci beszéd

U.S. Government Shutdown May Impact Release of Canadian Trade Data -- Market Talk

2025. okt. 7. 14:52 UTC

Eredményjelentés

These Stocks Are Moving the Most Today: Tesla, AMD, Ford, Dell, IBM, AppLovin, Trilogy Metals, Aehr, and More -- Barrons.com

Társak összehasonlítása

Árváltozás

Arbutus Biopharma Corp Előrejelzés

Értékelési konszenzus

By TipRanks

0 ratings

0

Vétel

0

Tartás

0

Eladás

Technikai pontszám

By Trading Central

3.255 / 3.365Támogatás & ellenállás

Rövid táv

Weak Bearish Evidence

Középtáv

Bullish Evidence

Hosszú táv

Weak Bullish Evidence

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Arbutus Biopharma Corp

Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection in the United States. Its HBV product pipeline consists of imdusiran (AB-729), a proprietary subcutaneously-delivered RNAi therapeutic product candidate that suppresses all HBV antigens, including HBsAg expression. The company's research and development programs include AB-101, an oral PD-L1 inhibitor to reawaken patients' HBV-specific immune system; and small molecule antiviral medicines to treat coronaviruses, including COVID-19. It has licensing agreements with Gritstone Oncology, Inc; Alnylam Pharmaceuticals, Inc.; Qilu Pharmaceuticals Co, Ltd; Assembly Biosciences, Inc.; Acuitas Therapeutics, Inc.; and Antios Therapeutics, Inc. Arbutus Biopharma Corporation also has a clinical collaboration agreement with Barinthus Biotherapeutics plc to evaluate VTP-300. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation is headquartered in Warminster, Pennsylvania.
help-icon Live chat